Bahl & Gaynor LLC lifted its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 38.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 861,488 shares of the financial services provider's stock after acquiring an additional 237,846 shares during the period. CME Group makes up about 1.1% of Bahl & Gaynor LLC's investment portfolio, making the stock its 25th biggest position. Bahl & Gaynor LLC owned 0.24% of CME Group worth $225,693,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. First Community Trust NA bought a new stake in shares of CME Group in the 3rd quarter valued at approximately $26,000. North Point Portfolio Managers Corp OH bought a new stake in CME Group in the third quarter valued at $26,000. Main Street Group LTD acquired a new position in CME Group during the first quarter worth $32,000. Compass Financial Management LLC raised its stake in CME Group by 471.4% during the third quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider's stock worth $31,000 after acquiring an additional 99 shares in the last quarter. Finally, Mowery & Schoenfeld Wealth Management LLC acquired a new position in CME Group during the second quarter worth $28,000. Institutional investors own 87.75% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have issued reports on CME. Barclays lifted their price objective on CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a report on Thursday, October 22nd. TD Cowen upped their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a "buy" rating in a report on Monday, October 5th. UBS Group increased their target price on shares of CME Group from $270.00 to $310.00 and gave the stock a "neutral" rating in a research report on Thursday, October 22nd. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a "buy" rating to a "hold" rating and cut their price target for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Finally, Piper Sandler restated an "overweight" rating and issued a $330.00 price target (up from $295.00) on shares of CME Group in a research report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $314.44.
View Our Latest Research Report on CME Group
CME Group Trading Up 1.5%
CME stock opened at $309.09 on Wednesday. The business has a fifty day moving average price of $283.95 and a 200 day moving average price of $281.05. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The stock has a market capitalization of $110.63 billion, a price-to-earnings ratio of 25.36, a P/E/G ratio of 3.72 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts' consensus estimates of $2.99 by $0.03. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.68 earnings per share. Analysts expect that CME Group Inc. will post 12.34 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 11th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group's dividend payout ratio (DPR) is presently 42.66%.
Insider Transactions at CME Group
In other CME Group news, Director Howard Siegel sold 2,000 shares of the business's stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $303.00, for a total value of $606,000.00. Following the completion of the transaction, the director directly owned 19,873 shares of the company's stock, valued at approximately $6,021,519. The trade was a 9.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Daniel Kaye sold 532 shares of the company's stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $304.17, for a total transaction of $161,818.44. Following the transaction, the director owned 4,313 shares in the company, valued at $1,311,885.21. The trade was a 10.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 33,511 shares of company stock worth $9,714,580. Corporate insiders own 0.30% of the company's stock.
CME Group Profile
(
Free Report)
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Featured Stories
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.